Exacerbation of Acanthamoeba keratitis in animals treated with anti-macrophage inflammatory protein 2 or antineutrophil antibodies.
about
A secondary wave of neutrophil infiltration causes necrosis and ulceration in lesions of experimental American cutaneous leishmaniasisRole of contact lens wear, bacterial flora, and mannose-induced pathogenic protease in the pathogenesis of amoebic keratitisProtease-activated receptor 2 (PAR2) is upregulated by Acanthamoeba plasminogen activator (aPA) and induces proinflammatory cytokine in human corneal epithelial cells.Acanthamoeba spp. as agents of disease in humansPathogenesis of acanthamoeba keratitis.IL-17A-mediated protection against Acanthamoeba keratitis.Pathogenic strains of Acanthamoeba are recognized by TLR4 and initiated inflammatory responses in the cornea.Microsporidial keratitis in patients with hot springs exposure.Significance of arachidonic acid in ocular infections and inflammation.Pathogenic Acanthamoeba spp secrete a mannose-induced cytolytic protein that correlates with the ability to cause disease.Pattern recognition receptors in microbial keratitisRole of phospholipase A₂ (PLA₂) inhibitors in attenuating apoptosis of the corneal epithelial cells and mitigation of Acanthamoeba keratitis.Ocular parasitoses and their immunology.Acanthamoeba Activates Macrophages Predominantly through Toll-Like Receptor 4- and MyD88-Dependent Mechanisms To Induce Interleukin-12 (IL-12) and IL-6.Acanthamoeba castellanii Genotype T4 Stimulates the Production of Interleukin-10 as Well as Proinflammatory Cytokines in THP-1 Cells, Human Peripheral Blood Mononuclear Cells, and Human Monocyte-Derived Macrophages
P2860
Q33773256-F429FB7C-D789-4030-ABD3-0A91DB3DCD24Q33796389-4577BF46-5E60-473F-AAC3-3CA4C16EFED0Q33799418-6E7BEAD1-346C-43FD-8BEB-5C24D1D4BC0DQ34190211-7503FE4A-3614-4A0D-8C2C-C80C55ED4B29Q34768834-39674C16-075B-4860-9787-247BAC35C451Q34810412-A3012FD4-4EA1-4FFF-9745-38B811FC6AD0Q35121965-C5069297-0A7E-4BC4-A393-21540E6567F3Q35689042-6F445837-8ECB-4E28-9E05-EE5EC092677CQ35737348-D062EBD0-A2DF-4769-87FE-F8AC5DA7ACBCQ36375101-80CF2BE1-B732-4643-BD8D-9A23C4128C63Q36750331-9F2DCFDD-E259-42BD-8BC9-5F51D6712F0BQ37091461-82D28751-B0E5-461D-95EB-6665DCE8E3F4Q37959537-44A7F903-11E1-436F-88A4-EA23F72B6CA3Q40276593-9F200395-30D4-4D97-A8FD-FAD4602930F4Q40592294-70827387-5D7C-4443-8A12-436B4382228C
P2860
Exacerbation of Acanthamoeba keratitis in animals treated with anti-macrophage inflammatory protein 2 or antineutrophil antibodies.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Exacerbation of Acanthamoeba k ...... or antineutrophil antibodies.
@ast
Exacerbation of Acanthamoeba k ...... or antineutrophil antibodies.
@en
Exacerbation of Acanthamoeba k ...... or antineutrophil antibodies.
@nl
type
label
Exacerbation of Acanthamoeba k ...... or antineutrophil antibodies.
@ast
Exacerbation of Acanthamoeba k ...... or antineutrophil antibodies.
@en
Exacerbation of Acanthamoeba k ...... or antineutrophil antibodies.
@nl
prefLabel
Exacerbation of Acanthamoeba k ...... or antineutrophil antibodies.
@ast
Exacerbation of Acanthamoeba k ...... or antineutrophil antibodies.
@en
Exacerbation of Acanthamoeba k ...... or antineutrophil antibodies.
@nl
P2093
P2860
P921
P1476
Exacerbation of Acanthamoeba k ...... or antineutrophil antibodies.
@en
P2093
P2860
P304
P356
10.1128/IAI.69.5.2988-2995.2001
P407
P577
2001-05-01T00:00:00Z